Govt warns against cough syrup use in kids after 11 deaths in MP, Rajasthan

Health ministry advisory urges rational use of cough syrups in children after 11 deaths in Madhya Pradesh and Rajasthan, though tests found no contamination in samples

Indian syrup, WHO, syrup, Iraq
The move follows reports of at least 11 deaths in Madhya Pradesh and Rajasthan due to kidney-related complications linked to cough syrups. | File Image
Sanket Koul New Delhi
3 min read Last Updated : Oct 03 2025 | 9:13 PM IST
The Centre on Friday issued an advisory calling for sensible use of cough syrups while cautioning against their prescription and dispensation to children below two years of age, as the death toll of kids due alleged consumption of contaminated cough syrups soared to 11.
 
The Directorate General of Health Services (DGHS) -- which comes under the Union health ministry -- also asked to exercise caution while prescribing cough syrups to kids below five years.
 
“These (cough syrups) are generally not recommended for ages below five years. And above that any use should follow careful clinical supervision and adherence to appropriate dosing,” the DGHS said in a statement.
 
At least nine children have died in Madhya Pradesh and two in Rajasthan after consuming contaminated cough syrups.
 
The cough syrups in question have been tested, along with a joint team visiting the regions affected by deaths. The team consisted of representatives from the National Centre for Disease Control (NCDC), National Institute of Virology (NIV) and Central Drugs Standard Control Organisation (CDSCO).  
 
“Various samples were collected in coordination with the state authorities including samples of various cough syrups. According to the test results, none of the samples contained Diethylene Glycol (DEG) or Ethylene Glycol (EG), contaminants that are known to cause serious kidney injury,” the health ministry said. 
 
The ministry said that product related to deaths in Rajasthan does not contain Propylene Glycol, which can be a potential source of contaminants or DEG/EG.
 
The syrup, which is a dextromethorphan-based formulation, was prescribed by community health centres. However, it is not recommended for paediatric use, according to officials in the know.
 
While there are questions on the manufacturer, the Centre has directed all healthcare facilities and clinical establishments to ensure procurement and dispensing of products manufactured under Good Manufacturing Practices (GMP) and formulated with pharmaceutical-grade excipients.   
 
While authorities have denied contamination of the cough syrup in question, a multi-disciplinary team comprising experts from NCDC, NIV, Indian Council of Medical Research (ICMR), AIIMS Nagpur and state health authorities is investigating all possible causes behind the reported cases.
 
“The Madhya Pradesh State Food and Drug Administration (SFDA) also tested three samples and confirmed the absence of DEG/EG,” the health ministry stated.
 
Further blood and cerebrospinal fluid (CSF) samples have been tested by NIV Pune for common pathogens, from which one case has been found positive for Leptospirosis.
 
“Samples of water, entomological vectors, and respiratory specimens are under further investigation by NEERI, NIV Pune, and other laboratories,” the note added. 
 
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Cough syrupMadhya Pradesh govtMadhya Pradesh

First Published: Oct 03 2025 | 7:58 PM IST

Next Story